Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. Summary
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

IGEA Pharma N : Declares All-Equity Offer for Blue Sky Natural Resources Unconditional

07/26/2021 | 02:30am EDT


ę MT Newswires 2021
All news about IGEA PHARMA N.V.
10/04IGEA PHARMA N.V. : Gbc ag to start equity coverage of igea pharma
DJ
10/04IGEA PHARMA N : GBC AG to start equity coverage of IGEA Pharma
PU
10/01IGEA PHARMA N : H1 Loss Narrows on Gains From Financial Liabilities, Sale of Assets
MT
09/30IGEA PHARMA N.V. : Igea discloses its half-2021 financials
DJ
09/30IGEA Pharma N.V. Reports Earnings Results for First Half 2021
CI
09/30Igea Pharma N.V. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
09/30IGEA PHARMA N : discloses its half-2021 financials
PU
09/27IGEA PHARMA N.V. : Igea has been granted the listing of the new shares from six exchange r..
DJ
09/27IGEA PHARMA N : has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
09/08IGEA PHARMA N : to submit the listing prospectus to the SIX following the business combina..
PU
More news
Financials (USD)
Sales 2020 0,08 M - -
Net income 2020 -1,13 M - -
Net Debt 2020 0,03 M - -
P/E ratio 2020 -11,9x
Yield 2020 -
Capitalization 109 M 109 M -
EV / Sales 2019 14 500x
EV / Sales 2020 194x
Nbr of Employees 2
Free-Float 99,3%
Chart IGEA PHARMA N.V.
Duration : Period :
IGEA Pharma N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Vicenzo Moccia Chairman-Management Board
Sector and Competitors
1st jan.Capi. (M$)
IGEA PHARMA N.V.-35.19%127
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.55.96%21 603
10X GENOMICS, INC.19.17%18 712
BIOMÉRIEUX-6.59%14 814
DIASORIN S.P.A.12.32%12 140
NATERA, INC.16.56%10 879